Binding Energy Partition of Promising IRAK-4 Inhibitor (Zimlovisertib) for the Treatment of COVID-19 Pneumonia.

The front cover artwork is provided by César A. Zapata-Acevedo and co-workers at the Institute of Chemistry of the National Autonomous University of Mexico, the IMDEA Materials Institute, the University of Manchester and Tecnológico de Monterrey Campus Santa Fe. The image shows the fragment-based drug design process for candidate Zimlovisertib. The Interacting Quantum Atoms method reveals the adequacy (or lack of) of the chemical changes throughout the design of this IRAK4 inhibitor. Read the full text of the Research Article at 10.1002/cphc.202200455.